标题
Phosphoprotein-based biomarkers as predictors for cancer therapy
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 31, Pages 18401-18411
出版商
Proceedings of the National Academy of Sciences
发表日期
2020-07-21
DOI
10.1073/pnas.2010103117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach
- (2018) Roberto Molinaro et al. ADVANCED MATERIALS
- Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery
- (2018) Jonathan O. Martinez et al. Theranostics
- Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer
- (2018) Sena Turkdogan et al. Journal of Otolaryngology-Head & Neck Surgery
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions
- (2017) Smruthi Vijayaraghavan et al. Targeted Oncology
- B-Raf Inhibition in the Clinic: Present and Future
- (2016) Warren Fiskus et al. Annual Review of Medicine
- Effects of the protein corona on liposome–liposome and liposome–cell interactions
- (2016) Ennio Tasciotti et al. International Journal of Nanomedicine
- The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery
- (2016) Claudia Corbo et al. Nanomedicine
- Biomimetic proteolipid vesicles for targeting inflamed tissues
- (2016) R. Molinaro et al. NATURE MATERIALS
- Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies
- (2016) Erika A. Newman et al. Seminars in Pediatric Surgery
- CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5–AP-1 axis
- (2016) Kangmin Zhuang et al. Cell Death & Disease
- Phosphorylation of kinase insert domain receptor by cyclin-dependent kinase 5 at serine 229 is associated with invasive behavior and poor prognosis in prolactin pituitary adenomas
- (2016) Weiyan Xie et al. Oncotarget
- Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity
- (2016) Zhenghu Chen et al. Scientific Reports
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker
- (2015) Kanglai Wei et al. World Journal of Surgical Oncology
- Differential expression of cell cycle regulators in CDK5-dependent medullary thyroid carcinoma tumorigenesis
- (2015) Karine Pozo et al. Oncotarget
- CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression
- (2014) Weiyan Xie et al. International Journal of Biological Sciences
- CDK2-dependent phosphorylation of Suv39H1 is involved in control of heterochromatin replication during cell cycle progression
- (2014) Su Hyung Park et al. NUCLEIC ACIDS RESEARCH
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- The Role of Cdk5 in Neuroendocrine Thyroid Cancer
- (2013) Karine Pozo et al. CANCER CELL
- Molecular mechanisms underlying RB protein function
- (2013) Frederick A. Dick et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Lessons learned and questions unanswered from use of multitargeted kinase inhibitors in medullary thyroid cancer
- (2013) Steven I. Sherman ORAL ONCOLOGY
- Progenitor Cell Line (hPheo1) Derived from a Human Pheochromocytoma Tumor
- (2013) Hans K. Ghayee et al. PLoS One
- Histopathology of gastrointestinal neuroendocrine neoplasms
- (2013) Kenichi Hirabayashi et al. Frontiers in Oncology
- Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway
- (2012) Abeba Demelash et al. MOLECULAR BIOLOGY OF THE CELL
- Deciphering the retinoblastoma protein phosphorylation code
- (2012) Seth M. Rubin TRENDS IN BIOCHEMICAL SCIENCES
- Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
- (2011) Razelle Kurzrock et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
- (2010) David Parry et al. MOLECULAR CANCER THERAPEUTICS
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Site-specifically phosphorylated forms of H1.5 and H1.2 localized at distinct regions of the nucleus are related to different processes during the cell cycle
- (2009) Heribert Talasz et al. CHROMOSOMA
- An Unusual Member of the Cdk Family: Cdk5
- (2008) Fatema A. Dhariwala et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion
- (2008) R. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
- (2007) Manuel C. Lemos et al. HUMAN MUTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started